The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Follitropin alfa

Australian Public Assessment Report

AusPAR

Attachment: Product Information for Follitropin alfa [PDF, 291.14 KB]

AusPAR: Follitropin alfa [Word, 1.02 MB]

AusPAR: Follitropin alfa [PDF, 506.91 KB]

Attachment: Product Information for Follitropin alfa [Word, 57.13 KB]

Device/Product Name

Ovaleap

Active ingredients

Follitropin alfa

AusPAR Date

3 May 2021

Published

19 May 2021

Submission Number

PM-2019-05982-1-5

Submission Type

New biosimilar medicine

Decision

Approved